Clinical Trial Update: Efficacy of Intravenous N-Acetylcysteine in Preventing Linezolid-Induced Thrombocytopenia in Critically Ill Patients [Phase 4]

View source ↗

Summary

A Phase 4 trial assessed whether intravenous N-acetylcysteine can prevent linezolid-induced thrombocytopenia in critically ill patients; the study has completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thrombocytopenia

Drugs mentioned

• N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: Helwan University | Conditions: Linezolid, Antioxidant | Phase 4 | Status: COMPLETED